Deliver Your News to the World

SmallCapNewsRelease:(OTC:KKUR) Technology Validated by Mayo Clinic


WEBWIRE

JERICHO, NY--(SmallCapNewsRelease)--January 5th, 2009 ChromoCure, Inc. (OTC:KKUR) announced today that the basis of their company’s technology has been confirmed by the Mayo Clinic.

The findings of the Mayo Clinic tests are in the current issue of the medical journal Cancer Cell (http://www.cell.com/cancer-cell/fulltext/S1535-6108(09)00387-0). The publication of the findings should enhance ChromoCures activities to promote their proprietary cancer detection system.

ChromoCure’s technology can detect the single characteristic found in 100% of all cancer at all stages which is never found in normal cells. The technology can also measure the level of cancer present and its stage of progression.

To view the entire press release please visit http://finance.yahoo.com/news/ChromoCure-Announces-Mayo-iw-1004762477.html?x=0&.v=1

SmallCapNewsRelease gainers are On Track Innovations (NASDAQ:OTIV) First Federal of Northern Michigan Bancorp (NASDAQ:FFNM) Universal Power (AMEX:UPG) Henry Bros. Electronics (NASDAQ:HBE) Amcore Financial (NASDAQ:AMFI) Superconductor Technologies (NASDAQ:SCON) Aegean Marine Petro (NYSE:ANW) Melco Crown Entertainment (NASDAQ:MPEL)

SmallCapNewsRelease decliners are MannKind Corp (NASDAQ:MNKD) Microvision (NASDAQ:MVISW) GlobalOptions Group (NASDAQ:GLOI) Brightpoint (NASDAQ:CELL) Carver Bancorp (NASDAQ:CARV) Spartan Stores (NASDAQ:SPTN) MidWestOne Financial (NASDAQ:MOFG) Birks & Mayors (AMEX:BMJ)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid Small Cap News Release twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation, do no trading of any kind and send no faxes or emails.



WebWireID110277




 
 KKUR
 Cancer
 Penny Stock
 Small Cap
 Chromocure


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.